Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.

15 Oct 2012

White blood cell variation can help predict non-blood cancers

Postdoctoral Research Fellow Devin Koestler is a biostatistician in the Geisel School of Medicine at Dartmouth. He develops and applies statistical methods to large volumes of data, seeking new approaches for understanding disease, cancer in particular. Koestler and his colleagues are investigating the potential use of white blood cell variation as a diagnostic, predictive, and research tool in the study of non-blood cancers.

15 Oct 2012

Database of drug-induced liver injury now available from NIH

A free source of evidence-based information for health care professionals and for researchers studying liver injury associated with prescription and over-the-counter drugs, herbals, and dietary supplements is now available from the National Institutes of Health. Researchers and health care professionals can use the LiverTox database to identify basic and clinical research questions to be answered and to chart optimal ways to diagnose and control drug-induced liver injury.

15 Oct 2012

Theragenics enters second amended and restated credit agreement with Wells Fargo

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association.

11 Oct 2012

Spanish and British scientists design new blood test to identify aggressive prostate cancer

Scientists from the Spanish National Cancer Research Centre (CNIO) in Madrid, along with British colleagues from the Institute for Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust, have developed a test that studies genetic patterns in blood cells to detect advanced-stage prostate cancer.

10 Oct 2012

EHRs enhance quality of patient care in community-based settings

A new study by Weill Cornell Medical College researchers, published in the Journal of General Internal Medicine, provides compelling evidence that electronic health records (EHRs) enhance the quality of patient care in a community-based setting with multiple payers, which is representative of how medicine is generally practiced across the United States.

10 Oct 2012

New blood test can read genetic changes in prostate cancer

Scientists have designed a blood test that reads genetic changes like a barcode - and can pick out aggressive prostate cancers by their particular pattern of gene activity.

9 Oct 2012

Patient navigation services can reduce dangerous delays in identification of breast cancer

Today researchers from The George Washington University published a study showing that breast cancer patients can reduce potentially dangerous delays in the identification of breast cancer with the assistance of patient navigation services.

8 Oct 2012

New gene test can detect pre-cancerous cells in patients with mouth lesions

Researchers from Queen Mary, University of London have developed a new gene test that can detect pre-cancerous cells in patients with benign-looking mouth lesions. The test could potentially allow at-risk patients to receive earlier treatment, significantly improving their chance of survival.

5 Oct 2012

IDIBELL, Universitat Politècnica de Catalunya patent novel system to improve lung cancer diagnosis

The system guides physicians by describing the best bronchoscope route from the trachea to a peripheral lung lesion. It avoids futile examinations and minimises potential risk for the patient.

5 Oct 2012

Key tips on how to sleep better, have more sex and stress less

Making the time to take care of your body and fulfill your needs becomes increasingly more difficult with the pressures and stresses of a demanding schedule, fast-paced job and the increasing number of distractions around us.

4 Oct 2012

Simple new test can monitor treatment of eosinophilic esophagitis

A simple new test, in which the patient swallows a string, can monitor treatment of eosinophilic esophagitis as effectively as an invasive, expensive and uncomfortable procedure that risks complications, particularly in children.

4 Oct 2012

Routine screening influences outcomes in prostate cancer after surgery

Men who undergo radical prostatectomy for a tumor that was detected by screening show better long-term outcomes than their peers who undergo the surgery after opportunistic diagnosis, study results show.

3 Oct 2012

Study examines newly proposed DSM-5 criteria for autism spectrum disorder

Parents should not worry that proposed changes to the medical criteria redefining a diagnosis of autism will leave their children excluded and deemed ineligible for psychiatric and medical care, says a team of researchers led by psychologists at Weill Cornell Medical College.

3 Oct 2012

Water diffusion measurements with MRI could decrease false-positive breast cancer results, biopsies

Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology. Researchers said the technique also could improve patient management by differentiating high-risk lesions requiring additional workup from other non-malignant subtypes.

3 Oct 2012

Thermal imaging camera monitors pain processing in patients suffering from small fiber neuropathy

Early results from the NeuroSIPE* programme 'Beyond Pain' project, in research funded by the Dutch Technology Foundation STW, demonstrate how a FLIR SC5600 thermal imaging camera has been used as an effective, non-invasive tool for monitoring of pain processing in the central nervous system of patients suffering from small fiber neuropathy.

2 Oct 2012

Takeda, Seattle Genetics announce preliminary data from brentuximab vedotin phase I study on sALCL

Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, and Seattle Genetics, Inc., today announced preliminary data from one arm of a three arm phase I, open-label, multicenter study designed to determine the safety and activity of sequential and combination treatment approaches of brentuximab vedotin with CHOP or CH-P chemotherapy in newly diagnosed patients with CD30-positive mature T- and NK- cell lymphomas.

1 Oct 2012

Study opens new door to more personalized treatment of advanced breast cancer

For the first time, researchers have conducted a large trial in which they tested the entire genome of individual breast cancers to help personalize treatment. They released their findings at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

1 Oct 2012

September issue of JNCCN publishes two prostate cancer articles

Julio M. Pow-Sang, M.D., chair of Moffitt Cancer Center's Department of Genitourinary Oncology, and colleagues have published two prostate cancer articles in the September issue of JNCCN - The Journal of the National Comprehensive Cancer Network. The articles review and clarify recent updates made to the National Comprehensive Cancer Network's (NCCN) guidelines for the screening and treatment of prostate cancer.

29 Sep 2012

Contrast-enhanced ultrasound effective in diagnosing men with high-grade prostate cancer

Contrast-enhanced ultrasound was found to better detect high-grade prostate cancer than conventional methods, making it a more appropriate approach for screening clinically important cancers and monitoring low-risk ones with less biopsies, researchers from Thomas Jefferson University and Hospitals conclude in a phase III study published online in September in the Journal of Urology.

28 Sep 2012

Biopsy News and Research

Further Reading

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

White blood cell variation can help predict non-blood cancers

Database of drug-induced liver injury now available from NIH

Theragenics enters second amended and restated credit agreement with Wells Fargo

Spanish and British scientists design new blood test to identify aggressive prostate cancer

EHRs enhance quality of patient care in community-based settings

New blood test can read genetic changes in prostate cancer

Patient navigation services can reduce dangerous delays in identification of breast cancer

New gene test can detect pre-cancerous cells in patients with mouth lesions

IDIBELL, Universitat Politècnica de Catalunya patent novel system to improve lung cancer diagnosis

Key tips on how to sleep better, have more sex and stress less

Simple new test can monitor treatment of eosinophilic esophagitis

Routine screening influences outcomes in prostate cancer after surgery

Study examines newly proposed DSM-5 criteria for autism spectrum disorder

Water diffusion measurements with MRI could decrease false-positive breast cancer results, biopsies

Thermal imaging camera monitors pain processing in patients suffering from small fiber neuropathy

Takeda, Seattle Genetics announce preliminary data from brentuximab vedotin phase I study on sALCL

Study opens new door to more personalized treatment of advanced breast cancer

September issue of JNCCN publishes two prostate cancer articles

Contrast-enhanced ultrasound effective in diagnosing men with high-grade prostate cancer

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News